FORDYCE MARSHALL (President and CEO) received a stock award from VERA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/6/2026ACC: 0001859453-26-000002
DirectorOfficer· President and CEO
Since May 2021
+206.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
206.30K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+68.80K
Price / share
—
Trade value
—
% of position
33.5%
2/4/2026
205.29K→274.09K
Total
Net shares
+68.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/4/2026 | A · Award | +68.80K | — | — | 33.5% | 205.29K | 274.09K |
| Total | +68.80K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
137.50K shares
Shares
+137.50K
Strike price
42.74
Held after
137.50K
Exercisable
—
2/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock137.50K shares | 2/4/2026 | A · Award | +137.50K | 42.74 | — | 137.50K |
Non-Derivative Holdings (Post-Transaction)2
Class A Common Stock
IndirectShares owned99.08K
Class A Common Stock
IndirectShares owned122.95K
Total
222.03K indirect222.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 99.08K | Indirect |
| Class A Common Stock | 122.95K | Indirect |
| Total | 222.03K | 222.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported